AAAAAA
Results:
1-7
|
Results: 7
Authors:
Rice, DP
Fillit, HM
Max, W
Knopman, DS
Lloyd, JR
Duttagupta, S
Citation: Dp. Rice et al., Prevalence, costs, and treatment of Alzheimer's disease and related dementia: A managed care perspective, AM J M CARE, 7(8), 2001, pp. 809-818
Authors:
Neumann, PJ
Hammitt, JK
Mueller, C
Fillit, HM
Hill, J
Tetteh, NA
Kosik, KS
Citation: Pj. Neumann et al., Public attitudes about genetic testing for Alzheimer's disease, HEAL AFFAIR, 20(5), 2001, pp. 252-264
Authors:
Fillit, HM
Citation: Hm. Fillit, The pharmacoeconomics of Alzheimer's disease, AM J M CARE, 6(22), 2000, pp. S1139-S1148
Authors:
Fillit, HM
Citation: Hm. Fillit, Managed care decisions in Alzheimer's disease, AM J M CARE, 6(22), 2000, pp. S1149-S1160
Authors:
Fillit, HM
Gutterman, EM
Brooks, RL
Citation: Hm. Fillit et al., Impact of donepezil on caregiving burden for patients with Alzheimer's disease, INT PSYCHOG, 12(3), 2000, pp. 389-401
Authors:
Yu, HN
Tyrrell, D
Cashel, J
Guo, NH
Vogel, T
Sipes, JM
Lam, L
Fillit, HM
Hartman, J
Mendelovitz, S
Panel, A
Roberts, DD
Citation: Hn. Yu et al., Specificities of heparin-binding sites from the amino-terminus and type 1 repeats of thrombospondin-1, ARCH BIOCH, 374(1), 2000, pp. 13-23
Authors:
Fillit, HM
Futterman, R
Orland, BI
Chim, T
Susnow, L
Picariello, GP
Scheye, EC
Spoeri, RK
Roglieri, JL
Warburton, SW
Citation: Hm. Fillit et al., Polypharmacy management in medicare managed care: Changes in prescribing by primary care physicians resulting from a program promoting medication reviews, AM J M CARE, 5(5), 1999, pp. 587-594
Risultati:
1-7
|